An Improved, Practical, and Scalable Five-Step Synthesis of Psilocybin
Robert B. Kargbo, Alexander M. Sherwood, Poncho Meisenheimer, Gary Tarpley
Synthesis January 8, 2020 DOI: 10.1055/s-0039-1691565 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Chemical synthesis protocol Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Keywords | Yield engineering Combinatorial chemistry Hallucinogen Pharmacology Alkaloids |
| Citations | 31 |
| Key points | An improved synthesis of psilocybin achieves 23% overall yield in five steps from an inexpensive acetoxyindole starting material without chromatography or aqueous workup. |
Abstract
Described herein is an improved synthesis of 3-[2-(dimethylamino)ethyl]-1H-indol-4-yl dihydrogen phosphate (psilocybin). The protocol outlines: synthesis of multigram quantities of psilocybin, identification of critical in-process parameters, and isolation of psilocybin without the use of chromatography, TLC, or aqueous workup. The synthesis furnishes psilocybin in five steps in 23% overall yield from an inexpensive acetoxyindole starting material. With specific focus on process control and impurity fate and removal, the improved procedure is amenable to providing high-quality psilocybin.
Citations in the library
Cited by 25
- Psilocybin: from ancient magic to modern medicine The Journal of Antibiotics May 12, 2020
- Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice Journal of Psychopharmacology April 28, 2024
- Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin Chemistry - A European Journal February 26, 2020
- Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin ACS Omega July 1, 2020
- “Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli” Biotechnology and Bioengineering June 20, 2023
and 20 more in the library
Cites 21
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology April 26, 2017
and 16 more in the library